Cited by 36

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Role of the endolysosomal pathway and exosome release in tau propagation

Yan, Minli, Zheng, Tingting·2021·Neurochemistry International

Abstract

The progressive deposition of misfolded and aggregated forms of Tau protein in the brain is a pathological hallmark of tauopathies, such as Alzheimer's disease (AD) and frontotemporal degeneration (FTD). The misfolded Tau can be released into the extracellular space and internalized by neighboring cells, acting as seeds to trigger the robust conversion of soluble Tau into insoluble filamentous aggregates in a prion-like manner, ultimately contributing to the progression of the disease. However, molecular mechanisms accountable for the propagation of Tau pathology are poorly defined. We reviewed the Tau processing imbalance in endosomal, lysosomal, and exosomal pathways in AD. Increased exosome release counteracts the endosomal-lysosomal dysfunction of Tau processing but increases the number of aggregates and the propagation of Tau. This review summarizes our current understanding of the underlying tauopathy mechanisms with an emphasis on the emerging role of the endosomal-lysosomal-exosome pathways in this process. The components CHMP6, TSG101, and other components of the ESCRT complex, as well as Rab GTPase such as Rab35 and Rab7A, regulate vesicle cargoes routing from endosome to lysosome and affect Tau traffic, degradation, or secretion. Thus, the significant molecular pathways that should be potential therapeutic targets for treating tauopathies are determined.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neuint.2021.104988

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Extracellular tau can be internalized and trafficked to endosomes and lysosomes.

    “Given that extracellular tau can be internalized and trafficked to endosomes and lysosomes (Yan and Zheng 2021), we determined whether SORLA modulation can alter tau trafficking and uptake in cultured neurons.”

    From SORLA up-regulation suppresses pathological effects in aged tauopathy mouse brain (2026) · cites this paper as Yan and Zheng 2021

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 145

  1. Aamodt, 1984, Microtubule-associated proteins connect microtubules and neurofilaments in vitro, Biochemistry, 23, 6023, 10.1021/bi00320a019 · DOI
  2. Alvarez-Erviti, 2011, Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission, Neurobiol. Dis., 42, 360, 10.1016/j.nbd.2011.01.029 · DOI
  3. Ando, 2013, Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains, Acta Neuropathol., 125, 861, 10.1007/s00401-013-1111-z · DOI · Paper page
  4. Ando, 2020, Picalm reduction exacerbates tau pathology in a murine tauopathy model, Acta Neuropathol., 139, 773, 10.1007/s00401-020-02125-x · DOI
  5. Andrei, 1999, The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles, Mol. Biol. Cell, 10, 1463, 10.1091/mbc.10.5.1463 · DOI
  6. Annunziata, 2013, Lysosomal NEU1 deficiency affects amyloid precursor protein levels and amyloid-beta secretion via deregulated lysosomal exocytosis, Nat. Commun., 4, 2734, 10.1038/ncomms3734 · DOI · Paper page
  7. Arbo, 2020, Endosomal dysfunction impacts extracellular vesicle release: central role in Abeta pathology, Ageing Res. Rev., 58, 10.1016/j.arr.2019.101006 · DOI
  8. Armstrong, 2014, Lysosomal network proteins as potential novel CSF biomarkers for Alzheimer's disease, NeuroMolecular Med., 16, 150, 10.1007/s12017-013-8269-3 · DOI
  9. Asai, 2015, Depletion of microglia and inhibition of exosome synthesis halt tau propagation, Nat. Neurosci., 18, 1584, 10.1038/nn.4132 · DOI · Paper page
  10. Baker, 2016, Extracellular vesicles containing P301L mutant tau accelerate pathological tau phosphorylation and oligomer formation but do not seed mature neurofibrillary tangles in ALZ17 mice, J Alzheimers Dis, 54, 1207, 10.3233/JAD-160371 · DOI · Paper page
  11. Bakker, 2012, Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment, Neuron, 74, 467, 10.1016/j.neuron.2012.03.023 · DOI
  12. Banfer, 2018, Molecular mechanism to recruit galectin-3 into multivesicular bodies for polarized exosomal secretion, Proc. Natl. Acad. Sci. U. S. A., 115, E4396, 10.1073/pnas.1718921115 · DOI
  13. Bertrand, 2013, Non-invasive, in vivo monitoring of neuronal transport impairment in a mouse model of tauopathy using MEMRI, Neuroimage, 64, 693, 10.1016/j.neuroimage.2012.08.065 · DOI
  14. Bissig, 2013, Lipid sorting and multivesicular endosome biogenesis, Cold Spring Harb Perspect Biol, 5, 10.1101/cshperspect.a016816 · DOI · Paper page
  15. Bondulich, 2016, Tauopathy induced by low level expression of a human brain-derived tau fragment in mice is rescued by phenylbutyrate, Brain, 139, 2290, 10.1093/brain/aww137 · DOI
  16. Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol. Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 · DOI · Paper page
  17. Bucci, 1992, The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway, Cell, 70, 715, 10.1016/0092-8674(92)90306-W · DOI
  18. Bucci, 2000, Rab7: a key to lysosome biogenesis, Mol. Biol. Cell, 11, 467, 10.1091/mbc.11.2.467 · DOI
  19. Calafate, 2015, Synaptic contacts enhance cell-to-cell tau pathology propagation, Cell Rep., 11, 1176, 10.1016/j.celrep.2015.04.043 · DOI
  20. Calafate, 2016, Loss of Bin1 promotes the propagation of tau pathology, Cell Rep., 17, 931, 10.1016/j.celrep.2016.09.063 · DOI · Paper page
  21. Canfield, 2017, An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells, J. Neurochem., 140, 874, 10.1111/jnc.13923 · DOI · Paper page
  22. Carmona, 2018, The genetic landscape of Alzheimer disease, Handb. Clin. Neurol., 148, 395, 10.1016/B978-0-444-64076-5.00026-0 · DOI
  23. Carosi, 2020, Retromer regulates the lysosomal clearance of MAPT/tau, Autophagy, 1
  24. Cataldo, 2008, Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects, Am. J. Pathol., 173, 370, 10.2353/ajpath.2008.071053 · DOI
  25. Chapuis, 2013, Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology, Mol. Psychiatr., 18, 1225, 10.1038/mp.2013.1 · DOI · Paper page
  26. Chivet, 2014, Exosomes secreted by cortical neurons upon glutamatergic synapse activation specifically interact with neurons, J. Extracell. Vesicles, 3, 24722, 10.3402/jev.v3.24722 · DOI · Paper page
  27. Clavaguera, 2013, Brain homogenates from human tauopathies induce tau inclusions in mouse brain, Proc. Natl. Acad. Sci. U. S. A., 110, 9535, 10.1073/pnas.1301175110 · DOI
  28. Clayton, 2015, Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology, Acta Neuropathol., 130, 511, 10.1007/s00401-015-1475-3 · DOI · Paper page
  29. Colacurcio, 2018, Dysfunction of autophagy and endosomal-lysosomal pathways: roles in pathogenesis of Down syndrome and Alzheimer's Disease, Free Radic. Biol. Med., 114, 40, 10.1016/j.freeradbiomed.2017.10.001 · DOI · Paper page
  30. Colombo, 2014, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, Annu. Rev. Cell Dev. Biol., 30, 255, 10.1146/annurev-cellbio-101512-122326 · DOI · Paper page
  31. Dujardin, 2014, Ectosomes: a new mechanism for non-exosomal secretion of tau protein, PloS One, 9, 10.1371/journal.pone.0100760 · DOI
  32. Duran, 2010, Unconventional secretion of Acb1 is mediated by autophagosomes, J. Cell Biol., 188, 527, 10.1083/jcb.200911154 · DOI · Paper page
  33. Eitan, 2016, Impact of lysosome status on extracellular vesicle content and release, Ageing Res. Rev., 32, 65, 10.1016/j.arr.2016.05.001 · DOI
  34. Fan, 2001, Cholesterol-dependent modulation of tau phosphorylation in cultured neurons, J. Neurochem., 76, 391, 10.1046/j.1471-4159.2001.00063.x · DOI
  35. Fontaine, 2016, DnaJ/Hsc70 chaperone complexes control the extracellular release of neurodegenerative-associated proteins, EMBO J., 35, 1537, 10.15252/embj.201593489 · DOI
  36. Fraldi, 2016, Brain disorders due to lysosomal dysfunction, Annu. Rev. Neurosci., 39, 277, 10.1146/annurev-neuro-070815-014031 · DOI
  37. Frankel, 2018, ESCRT-dependent cargo sorting at multivesicular endosomes, Semin. Cell Dev. Biol., 74, 4, 10.1016/j.semcdb.2017.08.020 · DOI
  38. Galloway, 1983, Acidification of macrophage and fibroblast endocytic vesicles in vitro, Proc. Natl. Acad. Sci. U. S. A., 80, 3334, 10.1073/pnas.80.11.3334 · DOI
  39. Gao, 2020, Vps35 deficiency impairs cdk5/p35 degradation and promotes the hyperphosphorylation of tau protein in retinal ganglion cells, Invest. Ophthalmol. Vis. Sci., 61, 1, 10.1167/iovs.61.1.1 · DOI
  40. Ginsberg, 2010, Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression, Biol. Psychiatr., 68, 885, 10.1016/j.biopsych.2010.05.030 · DOI · Paper page
  41. Ginsberg, 2010, Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease, J Alzheimers Dis, 22, 631, 10.3233/JAD-2010-101080 · DOI
  42. Girard, 2014, Rab7 is functionally required for selective cargo sorting at the early endosome, Traffic, 15, 309, 10.1111/tra.12143 · DOI
  43. Goedert, 2017, Propagation of tau aggregates and neurodegeneration, Annu. Rev. Neurosci., 40, 189, 10.1146/annurev-neuro-072116-031153 · DOI · Paper page
  44. Goetzl, 2015, Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease, Neurology, 85, 40, 10.1212/WNL.0000000000001702 · DOI · Paper page
  45. Griffiths, 2016, Secretion from myeloid cells: secretory lysosomes, Microbiol. Spectr., 4, 10.1128/microbiolspec.MCHD-0030-2016 · DOI · Paper page
  46. Gruenberg, 2020, Life in the lumen: the multivesicular endosome, Traffic, 21, 76, 10.1111/tra.12715 · DOI
  47. Hamano, 2008, Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression, Eur. J. Neurosci., 27, 1119, 10.1111/j.1460-9568.2008.06084.x · DOI · Paper page
  48. Hanson, 2012, Multivesicular body morphogenesis, Annu. Rev. Cell Dev. Biol., 28, 337, 10.1146/annurev-cellbio-092910-154152 · DOI
  49. Holler, 2014, Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology, J Alzheimers Dis, 42, 1221, 10.3233/JAD-132450 · DOI · Paper page
  50. Huotari, 2011, Endosome maturation, EMBO J., 30, 3481, 10.1038/emboj.2011.286 · DOI
  51. Hurley, 2015, ESCRTs are everywhere, EMBO J., 34, 2398, 10.15252/embj.201592484 · DOI
  52. Iba, 2013, Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy, J. Neurosci., 33, 1024, 10.1523/JNEUROSCI.2642-12.2013 · DOI · Paper page
  53. Iqbal, 2009, Mechanisms of tau-induced neurodegeneration, Acta Neuropathol., 118, 53, 10.1007/s00401-009-0486-3 · DOI · Paper page
  54. Ittner, 2010, Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models, Cell, 142, 387, 10.1016/j.cell.2010.06.036 · DOI · Paper page
  55. Jae, 2015, Rab7a and Rab27b control secretion of endothelial microRNA through extracellular vesicles, FEBS Lett., 589, 3182, 10.1016/j.febslet.2015.08.040 · DOI
  56. Kang, 2019, Autophagy-mediated secretory pathway is responsible for both normal and pathological tau in neurons, J Alzheimers Dis, 70, 667, 10.3233/JAD-190180 · DOI
  57. Karch, 2012, Extracellular Tau levels are influenced by variability in Tau that is associated with tauopathies, J. Biol. Chem., 287, 42751, 10.1074/jbc.M112.380642 · DOI
  58. Katsinelos, 2018, Unconventional secretion mediates the trans-cellular spreading of tau, Cell Rep., 23, 2039, 10.1016/j.celrep.2018.04.056 · DOI
  59. Kett, 2016, Endolysosomal dysfunction in Parkinson's disease: recent developments and future challenges, Mov. Disord., 31, 1433, 10.1002/mds.26797 · DOI
  60. Khanna, 2016, Therapeutic strategies for the treatment of tauopathies: hopes and challenges, Alzheimers Dement, 12, 1051, 10.1016/j.jalz.2016.06.006 · DOI
  61. Kim, 2016, Evidence that the rab5 effector APPL1 mediates APP-betaCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease, Mol. Psychiatr., 21, 707, 10.1038/mp.2015.97 · DOI · Paper page
  62. Kimura, 2014, Microtubule-associated protein tau is essential for long-term depression in the hippocampus, Philos. Trans. R. Soc. Lond. B Biol. Sci., 369, 20130144, 10.1098/rstb.2013.0144 · DOI · Paper page
  63. Klumperman, 2014, The complex ultrastructure of the endolysosomal system, Cold Spring Harb Perspect Biol, 6, 10.1101/cshperspect.a016857 · DOI
  64. Korkut, 2013, Regulation of postsynaptic retrograde signaling by presynaptic exosome release, Neuron, 77, 1039, 10.1016/j.neuron.2013.01.013 · DOI · Paper page
  65. Kouranti, 2006, Rab35 regulates an endocytic recycling pathway essential for the terminal steps of cytokinesis, Curr. Biol., 16, 1719, 10.1016/j.cub.2006.07.020 · DOI · Paper page
  66. Kowal, 2014, Biogenesis and secretion of exosomes, Curr. Opin. Cell Biol., 29, 116, 10.1016/j.ceb.2014.05.004 · DOI · Paper page
  67. Kramer-Albers, 2007, Oligodendrocytes secrete exosomes containing major myelin and stress-protective proteins: trophic support for axons?, Proteonomics Clin. Appl., 1, 1446, 10.1002/prca.200700522 · DOI
  68. Kunkle, 2019, Author Correction: genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing, Nat. Genet., 51, 1423, 10.1038/s41588-019-0495-7 · DOI
  69. Lambert, 2013, Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease, Nat. Genet., 45, 1452, 10.1038/ng.2802 · DOI · Paper page
  70. Lee, 2018, The roles of endo-lysosomes in unconventional protein secretion, Cells, 7, 10.3390/cells7110198 · DOI
  71. Lee, 2001, Neurodegenerative tauopathies, Annu. Rev. Neurosci., 24, 1121, 10.1146/annurev.neuro.24.1.1121 · DOI · Paper page
  72. Li, 2020, Full recovery of the Alzheimer's disease phenotype by gain of function of vacuolar protein sorting 35, Mol. Psychiatr., 25, 2630, 10.1038/s41380-019-0364-x · DOI
  73. Li, 2020, A pharmacological chaperone improves memory by reducing Abeta and tau neuropathology in a mouse model with plaques and tangles, Mol. Neurodegener., 15, 1, 10.1186/s13024-019-0350-4 · DOI · Paper page
  74. Lonati, 2018, Ischemic conditions affect rerouting of tau protein levels: evidences for alteration in tau processing and secretion in hippocampal neurons, J. Mol. Neurosci., 66, 604, 10.1007/s12031-018-1199-7 · DOI
  75. Love, 1995, Neurofibrillary tangles in Niemann-Pick disease type C, Brain, 118, 119, 10.1093/brain/118.1.119 · DOI
  76. Lowe, 2018, Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia, Brain, 141, 271, 10.1093/brain/awx320 · DOI
  77. Luzio, 2014, The biogenesis of lysosomes and lysosome-related organelles, Cold Spring Harb Perspect Biol, 6, 10.1101/cshperspect.a016840 · DOI · Paper page
  78. Luzio, 2007, Lysosomes: fusion and function, Nat. Rev. Mol. Cell Biol., 8, 622, 10.1038/nrm2217 · DOI
  79. Ma, 2019, Prion-like mechanisms in Parkinson's disease, Front. Neurosci., 13, 552, 10.3389/fnins.2019.00552 · DOI
  80. Malnar, 2014, Bidirectional links between Alzheimer's disease and Niemann-Pick type C disease, Neurobiol. Dis., 72 Pt A, 37, 10.1016/j.nbd.2014.05.033 · DOI
  81. Marks, 2013, Lysosome-related organelles: unusual compartments become mainstream, Curr. Opin. Cell Biol., 25, 495, 10.1016/j.ceb.2013.04.008 · DOI
  82. Marzella, 1981, Autophagy, heterophagy, microautophagy and crinophagy as the means for intracellular degradation, Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 36, 219, 10.1007/BF02912068 · DOI
  83. Mattsson, 2012, Miglustat treatment may reduce cerebrospinal fluid levels of the axonal degeneration marker tau in niemann-pick type C, JIMD Rep, 3, 45
  84. McMahon, 1997, Clathrin interacts specifically with amphiphysin and is displaced by dynamin, FEBS Lett., 413, 319, 10.1016/S0014-5793(97)00928-9 · DOI
  85. Merezhko, 2018, Secretion of tau via an unconventional non-vesicular mechanism, Cell Rep., 25, 2027, 10.1016/j.celrep.2018.10.078 · DOI · Paper page
  86. Meyerholz, 2005, Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation, Traffic, 6, 1225, 10.1111/j.1600-0854.2005.00355.x · DOI
  87. Miaczynska, 2004, Not just a sink: endosomes in control of signal transduction, Curr. Opin. Cell Biol., 16, 400, 10.1016/j.ceb.2004.06.005 · DOI
  88. Miranda, 2018, Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures, Nat. Commun., 9, 291, 10.1038/s41467-017-02533-w · DOI · Paper page
  89. Mohamed, 2013, Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission, Eur. J. Neurosci., 37, 1939, 10.1111/ejn.12229 · DOI
  90. Mohamed, 2014, Starvation and inhibition of lysosomal function increased tau secretion by primary cortical neurons, Sci. Rep., 4, 5715, 10.1038/srep05715 · DOI
  91. Moreau, 2014, PICALM modulates autophagy activity and tau accumulation, Nat. Commun., 5, 4998, 10.1038/ncomms5998 · DOI · Paper page
  92. Moyano, 2019, Proteasome 20S and Rab5 alteration after 24 h and 14 Days chlorpyrifos exposure lead to beta-amyloid and tau protein level increases and SN56 neuronal cell death, Chem. Res. Toxicol., 32, 1920, 10.1021/acs.chemrestox.9b00216 · DOI
  93. Nakajo, 2016, EHBP1L1 coordinates Rab8 and Bin1 to regulate apical-directed transport in polarized epithelial cells, J. Cell Biol., 212, 297, 10.1083/jcb.201508086 · DOI
  94. Nickel, 2009, Mechanisms of regulated unconventional protein secretion, Nat. Rev. Mol. Cell Biol., 10, 148, 10.1038/nrm2617 · DOI
  95. Nixon, 2005, Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases, Neurobiol. Aging, 26, 373, 10.1016/j.neurobiolaging.2004.09.018 · DOI
  96. Nixon, 2011, Autophagy failure in Alzheimer's disease--locating the primary defect, Neurobiol. Dis., 43, 38, 10.1016/j.nbd.2011.01.021 · DOI · Paper page
  97. Platta, 2011, Endocytosis and signaling, Curr. Opin. Cell Biol., 23, 393, 10.1016/j.ceb.2011.03.008 · DOI
  98. Podvin, 2020, Dysregulation of exosome cargo by mutant tau expressed in human-induced pluripotent stem cell (iPSC) neurons revealed by proteomics analyses, Mol. Cell. Proteomics, 19, 1017, 10.1074/mcp.RA120.002079 · DOI
  99. Polanco, 2018, Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons, Acta Neuropathol Commun, 6, 10, 10.1186/s40478-018-0514-4 · DOI
  100. Polanco, 2016, Extracellular vesicles isolated from the brains of rTg4510 mice seed tau protein aggregation in a threshold-dependent manner, J. Biol. Chem., 291, 12445, 10.1074/jbc.M115.709485 · DOI
  101. Pooler, 2013, Physiological release of endogenous tau is stimulated by neuronal activity, EMBO Rep., 14, 389, 10.1038/embor.2013.15 · DOI · Paper page
  102. Poteryaev, 2010, Identification of the switch in early-to-late endosome transition, Cell, 141, 497, 10.1016/j.cell.2010.03.011 · DOI · Paper page
  103. Querfurth, 2010, Alzheimer's disease, N. Engl. J. Med., 362, 329, 10.1056/NEJMra0909142 · DOI · Paper page
  104. Raiborg, 2009, The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins, Nature, 458, 445, 10.1038/nature07961 · DOI · Paper page
  105. Rajendran, 2014, Emerging roles of extracellular vesicles in the nervous system, J. Neurosci., 34, 15482, 10.1523/JNEUROSCI.3258-14.2014 · DOI · Paper page
  106. Raposo, 2013, Extracellular vesicles: exosomes, microvesicles, and friends, J. Cell Biol., 200, 373, 10.1083/jcb.201211138 · DOI · Paper page
  107. Reilly, 2017, Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation, Neurobiol. Dis., 106, 222, 10.1016/j.nbd.2017.06.005 · DOI
  108. Rodriguez, 2017, Rab7A regulates tau secretion, J. Neurochem., 141, 592, 10.1111/jnc.13994 · DOI
  109. Saffi, 2019, Lysosome fission: planning for an exit, Trends Cell Biol., 29, 635, 10.1016/j.tcb.2019.05.003 · DOI
  110. Sato, 2008, Regulation of endocytic recycling by C. elegans Rab35 and its regulator RME-4, a coated-pit protein, EMBO J., 27, 1183, 10.1038/emboj.2008.54 · DOI · Paper page
  111. Sawamura, 2003, Promotion of tau phosphorylation by MAP kinase Erk1/2 is accompanied by reduced cholesterol level in detergent-insoluble membrane fraction in Niemann-Pick C1-deficient cells, J. Neurochem., 84, 1086, 10.1046/j.1471-4159.2003.01596.x · DOI
  112. Schwarz, 2016, Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages, Brain, 139, 1539, 10.1093/brain/aww023 · DOI · Paper page
  113. Scott, 2014, Endosome maturation, transport and functions, Semin. Cell Dev. Biol., 31, 2, 10.1016/j.semcdb.2014.03.034 · DOI
  114. Seaman, 2012, The retromer complex - endosomal protein recycling and beyond, J. Cell Sci., 125, 4693
  115. Seshadri, 2010, Genome-wide analysis of genetic loci associated with Alzheimer disease, J. Am. Med. Assoc., 303, 1832, 10.1001/jama.2010.574 · DOI · Paper page
  116. Simon, 2012, Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles, FEBS Lett., 586, 47, 10.1016/j.febslet.2011.11.022 · DOI
  117. Simonetti, 2018, Endosomal sorting: architecture of the retromer coat, Curr. Biol., 28, R1350, 10.1016/j.cub.2018.10.040 · DOI
  118. Skowyra, 2018, Triggered recruitment of ESCRT machinery promotes endolysosomal repair, Science, 360, 10.1126/science.aar5078 · DOI · Paper page
  119. Small, 2015, Retromer in Alzheimer disease, Parkinson disease and other neurological disorders, Nat. Rev. Neurosci., 16, 126, 10.1038/nrn3896 · DOI · Paper page
  120. Small, 2017, Endosomal traffic jams represent a pathogenic hub and therapeutic target in alzheimer's disease, Trends Neurosci., 40, 592, 10.1016/j.tins.2017.08.003 · DOI · Paper page
  121. Stenmark, 2009, Rab GTPases as coordinators of vesicle traffic, Nat. Rev. Mol. Cell Biol., 10, 513, 10.1038/nrm2728 · DOI · Paper page
  122. Suzuki, 1995, Neurofibrillary tangles in Niemann-Pick disease type C, Acta Neuropathol., 89, 227, 10.1007/BF00309338 · DOI
  123. Tanaka, 2019, Seeding activity-based detection uncovers the different release mechanisms of seed-competent tau versus inert tau via lysosomal exocytosis, Front. Neurosci., 13, 1258, 10.3389/fnins.2019.01258 · DOI
  124. Tapper, 1990, Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion, Biochem. J., 272, 407, 10.1042/bj2720407 · DOI
  125. Tian, 2010, Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy, J. Cell. Biochem., 111, 488, 10.1002/jcb.22733 · DOI
  126. Tian, 2013, Dynamics of exosome internalization and trafficking, J. Cell. Physiol., 228, 1487, 10.1002/jcp.24304 · DOI
  127. Ugbode, 2019, Leaky endosomes push tau over the seed limit, J. Biol. Chem., 294, 18967, 10.1074/jbc.H119.011687 · DOI
  128. Urwin, 2010, Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations, Hum. Mol. Genet., 19, 2228, 10.1093/hmg/ddq100 · DOI
  129. Vagnozzi, 2019, Endosomal sorting and trafficking, the retromer complex and neurodegeneration, Mol. Psychiatr., 24, 857, 10.1038/s41380-018-0221-3 · DOI · Paper page
  130. van der Goot, 2006, Intra-endosomal membrane traffic, Trends Cell Biol., 16, 514, 10.1016/j.tcb.2006.08.003 · DOI
  131. van Olst, 2020, Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model, Neurobiol. Aging, 89, 89, 10.1016/j.neurobiolaging.2020.01.003 · DOI
  132. Vaz-Silva, 2018, Endolysosomal degradation of Tau and its role in glucocorticoid-driven hippocampal malfunction, EMBO J., 37, 10.15252/embj.201899084 · DOI · Paper page
  133. Victoria, 2017, The spread of prion-like proteins by lysosomes and tunneling nanotubes: implications for neurodegenerative diseases, J. Cell Biol., 216, 2633, 10.1083/jcb.201701047 · DOI
  134. Vidyadhara, 2019, Role of the endolysosomal system in Parkinson's disease, J. Neurochem., 150, 487, 10.1111/jnc.14820 · DOI
  135. Villarroya-Beltri, 2014, Sorting it out: regulation of exosome loading, Semin. Canc. Biol., 28, 3, 10.1016/j.semcancer.2014.04.009 · DOI
  136. Villemagne, 2019, Imaging of tau deposits in adults with Niemann-Pick type C disease: a case-control study, Eur. J. Nucl. Med. Mol. Imag., 46, 1132, 10.1007/s00259-019-4273-7 · DOI
  137. Winston, 2019, Neuronal exosome-derived human tau is toxic to recipient mouse neurons in vivo, J Alzheimers Dis, 67, 541, 10.3233/JAD-180776 · DOI
  138. Winston, 2016, Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile, Alzheimers Dement (Amst), 3, 63, 10.1016/j.dadm.2016.04.001 · DOI
  139. Wollert, 2009, Membrane scission by the ESCRT-III complex, Nature, 458, 172, 10.1038/nature07836 · DOI
  140. Wu, 2013, Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons, J. Biol. Chem., 288, 1856, 10.1074/jbc.M112.394528 · DOI · Paper page
  141. Wu, 2016, Neuronal activity enhances tau propagation and tau pathology in vivo, Nat. Neurosci., 19, 1085, 10.1038/nn.4328 · DOI · Paper page
  142. Xu, 2018, DNAJC5 facilitates USP19-dependent unconventional secretion of misfolded cytosolic proteins, Cell Discov, 4, 11, 10.1038/s41421-018-0012-7 · DOI
  143. Yamada, 2017, Extracellular tau and its potential role in the propagation of tau pathology, Front. Neurosci., 11, 667, 10.3389/fnins.2017.00667 · DOI
  144. Zervas, 2001, Neurons in Niemann-Pick disease type C accumulate gangliosides as well as unesterified cholesterol and undergo dendritic and axonal alterations, J. Neuropathol. Exp. Neurol., 60, 49, 10.1093/jnen/60.1.49 · DOI
  145. Zhang, 2004, Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice, Am. J. Pathol., 165, 843, 10.1016/S0002-9440(10)63347-0 · DOI

Cited by

Sorted by citations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review